Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)

ClinicalTrials.gov ID: NCT02240784

Public ClinicalTrials.gov record NCT02240784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Natural History Study of Acute Hepatic Porphyria (AHP) Patients With Recurrent Attacks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.

Study identification

NCT ID
NCT02240784
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Alnylam Pharmaceuticals
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Actual)
Primary completion
Apr 26, 2021 (Actual)
Completion
Apr 26, 2021 (Actual)
Last update posted
May 17, 2021

2014 – 2021

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Clinical Trial Site San Francisco California 94143 —
Clinical Trial Site Miami Florida 33136 —
Clinical Trial Site Ann Arbor Michigan 48109 —
Clinical Trial Site New York New York 10029 —
Clinical Trial Site Winston-Salem North Carolina 27157 —
Clinical Trial Site Philadelphia Pennsylvania 19107 —
Clinical Trial Site Galveston Texas 77555 —
Clinical Trial Site Salt Lake City Utah 84112 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02240784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 17, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02240784 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →